# US 2016/0256490 A1 · Acellular biologic composition and method of manufacture

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0256490 A1
- Document ID: US20160256490A1
- Status: Published application
- Kind: A1
- Application number: 14/682,523
- Filed: 2015-04-09
- Published: 2016-09-08
- Earliest claimed: 2015-03-06
- Assignees: Vivex Biomedical, Inc.
- Applicants: Vivex Biomedical Inc.
- Inventors: Wendy W. Weston; Miguel Quevedo; Stuart Oglesby; Gaëtan Jean-Robert Delcroix; Paul C. Schiller; Gianluca D'Ippolito; Timothy Ganey
- Web page: https://patentgrep.com/patent/US20160256490A1

## CPC

- C12N 5/0669: {Bone marrow stromal cells; Whole bone marrow (isolated stem cells from bone marrow C12N5/0647, C12N5/0663)}
- A01N 1/125: Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
- A01N 1/162: Temperature processes, e.g. following predefined temperature changes over time
- A61K 35/28: Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
- A61K 35/32: Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
- A61L 27/3604: {characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel}
- A61L 27/3608: {Bone, e.g. demineralised bone matrix [DBM], bone powder}
- A61L 27/365: {Bones}
- A61L 27/3691: {characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation}
- A61L 27/3834: {Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells}
- A61L 27/446: {with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46}
- A61L 27/50: Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials}
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 27/58: Materials at least partially resorbable by the body
- C08L 89/00: Compositions of proteins; Compositions of derivatives thereof
- A61K 2035/124: {the cells being hematopoietic, bone marrow derived or blood cells}
- A61K 2300/00: Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
- A61L 2430/00: Materials or treatment for tissue regeneration
- A61L 2430/02: for reconstruction of bones; weight-bearing implants
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)

## Abstract

A biological composition has a mixture of mechanically selected allogeneic biologic material derived from bone marrow. The mixture has non-whole cellular components including vesicular components and active and inactive components of biological activity, cell fragments, cellular excretions, cellular derivatives, and extracellular components. The mixture including non-whole cell fractions including one or more of exosomes, transcriptosomes, proteasomes, membrane rafts, lipid rafts. The mixture is compatible with biologic function.

## Claims

### Claim 1

A biological composition comprising:
a mixture of mechanically selected allogeneic biologic material derived from bone marrow having non-whole cellular components including vesicular components and active and inactive components of biological activity, cell fragments, cellular excretions, cellular derivatives, and extracellular components; and
wherein the mixture is compatible with biologic function.

### Claim 2 (depends on 1)

The biological composition of claim 1 further comprises bone particles, the bone particles being added to the mixture derived from bone marrow.

### Claim 3 (depends on 2)

The biological composition of claim 2 wherein the bone particles include a mixture of cortical bone particles and cancellous bone particles.

### Claim 4 (depends on 1)

The biological composition of claim 1 wherein the mixture of mechanically selected material derived from bone marrow further includes a select number of non-whole cell fractions including one or more of exosomes, transcriptosomes, proteasomes, membrane rafts, lipid rafts.

### Claim 5 (depends on 4)

The biological composition of claim 4 wherein the combination of non-whole cell components with a select number of the non-whole cell fractions sustains pluripotency in both graft or host cells or combinations thereof.

### Claim 6 (depends on 5)

The biological composition of claim 5 wherein the select number of the non-whole cell fractions sustains pluripotency in graft or host cells or combinations thereof includes differentiated committed cells and non-differentiated and non-committed cells.

### Claim 7 (depends on 2)

The biological composition of claim 2 wherein the biological composition is predisposed to demonstrate or support elaboration of active volume or spatial geometry consistent in morphology with that of endogenous bone.

### Claim 8 (depends on 1)

The biological composition of claim 1 wherein the biological composition extends regenerative resonance that compliments or mimics tissue complexity.

### Claim 9 (depends on 1)

The biological composition of claim 1 wherein the mixture is treated in a protectant or cryoprotectant prior to preservation or cryopreservation or freeze drying.

### Claim 10 (depends on 9)

The biological composition of claim 9 wherein the protectant or cryoprotectant creates a physical or electrical or chemical gradient or combination thereof for tissue regeneration.

### Claim 11 (depends on 10)

The biological composition of claim 10 wherein the gradient has a physical characteristic of modulus or topography such as charge density, field shape or cryo or chemo toxics tendencies.

### Claim 12 (depends on 10)

The biological composition of claim 10 wherein the gradient has a chemical characteristic of spatially changing compositions of density or species of functional molecules, wherein the molecules can offer a fixed catalytic function as a co-factor.

### Claim 13 (depends on 10)

The biological composition of claim 10 wherein the gradient has an electrical characteristic of charge based or pH based or electron affinities that confer metastability in biologic potential.

### Claim 14 (depends on 4)

The biological composition of claim 4 wherein the bone marrow mixture which is derived from a cadaver has separation-enhanced non-whole cell fractions vitality including one or more of the following: separating the fractions from cells heightens their vitality, reversing “arrest” of donors, responsive molecular coupling, matrix quest in neutralizing inflammation or satience by balancing stimulus for repair.

### Claim 15 (depends on 9)

The biological composition of claim 9 wherein the protectant or cryoprotectant is a polyampholyte.

### Claim 16 (depends on 8)

The biological composition of claim 8 wherein the regenerative resonance occurs in the presence or absence of a refractory response.

### Claim 17 (depends on 9)

The biological composition of claim 9 wherein the cryopreservation occurs at a temperature that is sub-freezing.

### Claim 18 (depends on 17)

The biological composition of claim 17 wherein the cryopreservation temperature is from 0 degrees C. to −200 degrees C.

### Claim 19 (depends on 1)

The biological composition of claim 1 wherein the mixture creates a physical or electrical or chemical gradient or combination thereof for tissue regeneration.

### Claim 20 (depends on 19)

The biological composition of claim 19 wherein the gradient has a physical characteristic such as modulus or topography.

### Claim 21 (depends on 19)

The biological composition of claim 19 wherein the gradient has a chemical characteristic such as spatially changing compositions of density or species of functional molecules.

### Claim 22 (depends on 19)

The biological composition of claim 19 wherein the gradient has an electrical characteristic such as charge based or pH based.

### Claim 23 (depends on 1)

The biological composition of claim 1 can be organelle fragments.

### Claim 24 (depends on 1)

The biological composition of claim 1 wherein active an inactive components of biological activity can be extants of the human metabolome.

### Claim 25 (depends on 9)

The biological composition of claim 9 wherein the composition is maintained at ambient temperature prior to freeze drying.

### Claim 26

A method of making a biological composition comprises the steps of:
collecting, recovering and processing bone marrow from a cadaver donor;
mechanically separating by spinning or tumbling cellular and non-cellular components of bone marrow from cadaverous bone;
separation by density gradient centrifugation;
collecting non-cellular fractions or non-cellular components or combinations thereof of predetermined density;
concentrating the non-cellular fractions or non-cellular components or combinations thereof by centrifugation and filtration;
washing the non-cellular fractions or non-cellular components or combinations thereof to create a mixture;
quantifying non-whole cell fraction concentration wherein the concentration is greater than zero;
suspending to a predetermined concentration in a polyampholyte cryoprotectant;
freezing the mixture at a predetermined controlled rate.

### Claim 27 (depends on 26)

A method of preparing the mixture for use made according to the method of claim 26 by the steps of:
thawing the mixture;
diluting the thawed mixture in saline without spinning; and
implanting the diluted mixture with or without the bone blend being intermixed by packing, injection or any other suitable means into a patient.

### Claim 28 (depends on 27)

The method of preparing the mixture for use made according to the method of claim 27 wherein the step of thawing the mixture occurs at a temperature of 37 degrees C. for 2 to 3 minutes in a warm water bath.

### Claim 29 (depends on 26)

A method of preparing the mixture for use made according to the method of claim 26 further includes the step of:
packaging a bone blend having particles in the size range of 100 to 300 μm of demineralized cortical bone, mineralized cortical bone and mineralized cancellous bone within the mixture.

### Claim 30 (depends on 26)

A method of preparing the mixture for use made according to the method of claim 26 further includes the step of:
packaging a bone blend having particles in the size range of 100 to 300 μm of demineralized cortical bone, mineralized cortical bone and mineralized cancellous bone separately from the mixture.
